Your browser doesn't support javascript.
Active surveillance of chemotherapy-related symptom burden in ambulatory cancer patients via the implementation of electronic patient-reported outcomes and sensor-enabled vital signs capture: protocol for a decentralised feasibility pilot study.
Offodile, Anaeze C; DiBrito, Sandra R; Finder, Janice P; Shete, Sanjay; Jain, Sanchita; Delgado, Domenica A; Miller, Christopher J; Davidson, Elenita; Overman, Michael J; Peterson, Susan K.
  • Offodile AC; Institute for Cancer Care Innovation, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA acoffodile@mdanderson.org.
  • DiBrito SR; Department of Plastic and Reconstructive Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Finder JP; Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Shete S; Division of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Jain S; Patient Experience Clinical Programs, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Delgado DA; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Miller CJ; Office of the Chief, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Davidson E; Office of the Chief, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Overman MJ; Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Peterson SK; Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
BMJ Open ; 12(4): e057693, 2022 04 05.
Article in English | MEDLINE | ID: covidwho-1779377
ABSTRACT

INTRODUCTION:

Remote patient monitoring (RPM) has emerged as a potential avenue for optimising the management of symptoms in patients undergoing chemotherapy. However, RPM is a complex, multilevel intervention with technology, workflow, contextual and patient experience components. The purpose of this pilot study is to determine the feasibility of RPM protocol implementation with respect to decentralised recruitment, patient retention, adherence to reporting recommendations, RPM platform usability and patient experience in ambulatory cancer patients at high risk for chemotherapy-related symptoms. METHODS AND

ANALYSIS:

This protocol describes a single-arm decentralised feasibility pilot study of technology-enhanced outpatient symptom management system in patients with gastrointestinal and thoracic cancer receiving chemotherapy and cancer care at a single site (MD Anderson Cancer Center, Houston Texas). An anticipated total of 25 patients will be recruited prior to the initiation of chemotherapy and provided with a set of validated questionnaires at enrollment and after our 1-month feasibility pilot trial period. Our intervention entails the self-reporting of symptoms and vital signs via a HIPAA-compliant, secure tablet interface that also enables (1) the provision of self-care materials to patients, (2) generation of threshold alerts to a dedicated call-centre and (3) videoconferencing. Vital sign information (heart rate, blood pressure, pulse, oxygen saturation, weight and temperature) will be captured via Bluetooth-enabled biometric monitoring devices which are integrated with the tablet interface. Protocolised triage and management of symptoms will occur in response to the alerts. Feasibility and acceptability metrics will characterise our recruitment process, protocol adherence, patient retention and usability of the RPM platform. We will also document the perceived effectiveness of our intervention by patients. ETHICS AND DISSEMINATION This study has been granted approval by the institutional review board of MD Anderson Cancer Center. We anticipate dissemination of our pilot and subsequent effectiveness trial results via presentations at national conferences and peer-reviewed publications in the relevant medical journals. Our results will also be made available to cancer survivors, their caregivers and hospital administration. TRIAL REGISTRATION NUMBER NCI202107464.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Watchful Waiting / Neoplasms Type of study: Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: BMJ Open Year: 2022 Document Type: Article Affiliation country: Bmjopen-2021-057693

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Watchful Waiting / Neoplasms Type of study: Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: BMJ Open Year: 2022 Document Type: Article Affiliation country: Bmjopen-2021-057693